These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35588266)
21. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. McCormick DL; Rao KV; Steele VE; Lubet RA; Kelloff GJ; Bosland MC Cancer Res; 1999 Feb; 59(3):521-4. PubMed ID: 9973192 [TBL] [Abstract][Full Text] [Related]
22. High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) prostate carcinogenesis. Inaguma S; Takahashi S; Ohnishi H; Suzuki S; Cho YM; Shirai T Cancer Sci; 2003 Nov; 94(11):974-9. PubMed ID: 14611674 [TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Arunkumar A; Vijayababu MR; Venkataraman P; Senthilkumar K; Arunakaran J Biol Pharm Bull; 2006 Feb; 29(2):375-9. PubMed ID: 16462049 [TBL] [Abstract][Full Text] [Related]
24. Chemopreventive Effect of Cinnamon and Its Bioactive Compounds in a Rat Model of Premalignant Prostate Carcinogenesis. Gopalakrishnan S; Dhaware M; Sudharma AA; Mullapudi SV; Siginam SR; Gogulothu R; Mir IA; Ismail A Cancer Prev Res (Phila); 2023 Mar; 16(3):139-151. PubMed ID: 36517462 [TBL] [Abstract][Full Text] [Related]
25. Gestational and lactational exposition to Di-N-butyl-phthalate (DBP) increases inflammation and preneoplastic lesions in prostate of wistar rats after carcinogenic N-methyl-N-nitrosourea (MNU) plus testosterone protocol. Peixoto AR; Santos TM; Brandt JZ; Delella FK; Gonçalves BF; Campos SG; Taboga SR; Favaro WJ; Domeniconi RF; Scarano WR Environ Toxicol; 2016 Oct; 31(10):1185-95. PubMed ID: 25728413 [TBL] [Abstract][Full Text] [Related]
26. Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone. Bosland MC; Prinsen MK; Kroes R Cancer Lett; 1983 Feb; 18(1):69-78. PubMed ID: 6218869 [TBL] [Abstract][Full Text] [Related]
27. The Lobund-Wistar rat model of prostate cancer. Pollard M J Cell Biochem Suppl; 1992; 16H():84-8. PubMed ID: 1289678 [TBL] [Abstract][Full Text] [Related]
28. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Bosland MC; Ford H; Horton L Carcinogenesis; 1995 Jun; 16(6):1311-7. PubMed ID: 7788848 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of γ-tocopherol-enriched diet on N-methyl-N-nitrosourea-induced epithelial dysplasia in rat ventral prostate. Sanches LD; Santos SA; Carvalho JR; Jeronimo GD; Favaro WJ; Reis MD; Felisbino SL; Justulin LA Int J Exp Pathol; 2013 Dec; 94(6):362-72. PubMed ID: 24205794 [TBL] [Abstract][Full Text] [Related]
30. Sodium arsenite does not affect prostate carcinogenesis in a chemically-hormonally-induced rat model. Bosland MC; Horton L Toxicology; 2022 May; 474():153212. PubMed ID: 35598691 [TBL] [Abstract][Full Text] [Related]
31. Induction of invasive carcinomas of the seminal vesicles and coagulating glands of F344 rats by administration of N-methylnitrosourea or N-nitrosobis(2-oxopropyl)amine and followed by testosterone propionate with or without high-fat diet. Shirai T; Yamamoto A; Iwasaki S; Tamano S; Masui T Carcinogenesis; 1991 Nov; 12(11):2169-73. PubMed ID: 1934306 [TBL] [Abstract][Full Text] [Related]
32. Increased phospho-AKT is associated with loss of the androgen receptor during the progression of N-methyl-N-nitrosourea-induced prostate carcinogenesis in rats. Liao Z; Wang S; Boileau TW; Erdman JW; Clinton SK Prostate; 2005 Jul; 64(2):186-99. PubMed ID: 15682402 [TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952 [TBL] [Abstract][Full Text] [Related]
34. A new proposed rodent model of chemically induced prostate carcinogenesis: distinct time-course prostate cancer progression in the dorsolateral and ventral lobes. Gonçalves BF; de Campos SG; Zanetoni C; Scarano WR; Falleiros LR; Amorim RL; Góes RM; Taboga SR Prostate; 2013 Aug; 73(11):1202-13. PubMed ID: 23620436 [TBL] [Abstract][Full Text] [Related]
35. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. McCormick DL; Rao KV Eur Urol; 1999; 35(5-6):464-7. PubMed ID: 10325506 [TBL] [Abstract][Full Text] [Related]
36. Testosterone treatment is a potent tumor promoter for the rat prostate. Bosland MC Endocrinology; 2014 Dec; 155(12):4629-33. PubMed ID: 25247471 [TBL] [Abstract][Full Text] [Related]
37. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system. Pollard M; Luckert PH Prostate; 1987; 11(3):219-27. PubMed ID: 3684782 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the chemopreventive potential of polyprenols from the needles of Murazov IG; Nyuganen AO; Artemyeva AS Vopr Pitan; 2021; 90(3):110-116. PubMed ID: 34264562 [TBL] [Abstract][Full Text] [Related]
39. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase. Bosland MC; Vega K; Horton L; Schlicht MJ Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936 [TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone. McCormick DL; Johnson WD; Kozub NM; Rao KV; Lubet RA; Steele VE; Bosland MC Carcinogenesis; 2007 Feb; 28(2):398-403. PubMed ID: 16952912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]